As of May 25, 2025, Aphria Inc (APHA.TO) reports a EV/EBITDA of N/A.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Aphria Inc's EV/EBITDA to Peers
To better understand Aphria Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Aphria Inc (APHA.TO) | - |
| Pacira Biosciences Inc (PCRX) | 68.77 |
| Corcept Therapeutics Inc (CORT) | 59.42 |
| SNDL Inc (SNDL) | 35.94 |
| Taro Pharmaceutical Industries Ltd (TARO) | 20.72 |
| ANI Pharmaceuticals Inc (ANIP) | 18.81 |
Compared to its competitors, Aphria Inc's EV/EBITDA is difficult to compare due to insufficient data.